risedronate sodium 150 MG Oral Tablet [Actonel]

RxCUI: 905030
RxNorm name: risedronate sodium 150 MG Oral Tablet [Actonel]
Display name: risedronate sodium 150 MG Oral Tablet [Actonel]
Full name: risedronate sodium 150 MG Oral Tablet [Actonel]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:38:50

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Actonel	RISEDRONATE SODIUM	Allergan, Inc.	24ed00e0-25e2-49a8-97fc-66c1b417dc0b	2026-02-04	Warnings, Adverse reactions	Exact identifier rxcui: 905030

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
24ed00e0-25e2-49a8-97fc-66c1b417dc0b	Actonel 150 MG Oral Tablet [PSN] · risedronate sodium 150 MG Oral Tablet [Actonel] [SBD] · Actonel 150 MG Oral Tablet [SY]	3	31	These highlights do not include all the information needed to use ACTONEL safely and effectively. See full prescribing information for ACTONEL. ACTONEL ® ( risedronate sodium ) tablets , for oral use Initial U.S. Approval: 199 8	20260204
4423d70a-b120-4653-bcf3-0c5ea8b97b0e	Actonel 150 MG Oral Tablet [PSN] · risedronate sodium 150 MG Oral Tablet [Actonel] [SBD] · Actonel 150 MG Oral Tablet [SY]	3	2	These highlights do not include all the information needed to use ACTONEL safely and effectively. See full prescribing information for ACTONEL. ACTONEL ® (risedronate sodium) tablets Initial U.S. Approval: 1998	20100324